Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
68 hedge funds and large institutions have $502M invested in Loxo Oncology, Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 5 closing their positions.
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
95% more capital invested
Capital invested by funds: $258M → $502M (+$244M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
33% more funds holding
Funds holding: 51 → 68 (+17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.4M |
| 3 |
AC
Aisling Capital
New York
|
+$9.23M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.75M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$22.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$22M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
-$2.81M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.34M |
| 5 |
SIM
Spark Investment Management
New York
|
-$939K |
LOXO Hedge Fund Activity: Q4 2015 in Review
68 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2015, worth a combined $502M — up 95% from $258M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LOXO positions and 5 closed out — a net gain of 17 holders — while 22 added to existing stakes and 16 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $72.6M. The largest seller was Deerfield Management, cutting an estimated $22.5M.
- 68 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2015, up from 51 in Q3 2015.
- Funds reported $502M of Loxo Oncology, Inc stock for Q4 2015, up 95% quarter-over-quarter.
- 22 funds opened new Loxo Oncology, Inc positions in Q4 2015 and 5 closed out, a net change of +17 holders.
- The largest Loxo Oncology, Inc buyer in Q4 2015 was Fidelity Investments, an estimated $72.6M added.
- The largest Loxo Oncology, Inc seller in Q4 2015 was Deerfield Management, an estimated $22.5M sold.
Based on aggregated 13F filings for Q4 2015.